Predictive Biomarkers Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

The Predictive Biomarkers Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Current Predictive Biomarkers Market Size and Its Estimated Growth Rate?
In recent times, the predictive biomarkers market size has seen stable growth. The market, which was valued at $20.05 billion in 2024, is expected to reach $20.96 billion in 2025, growing at a compound annual growth rate (CAGR) of 4.5%. The growth during the historic period can be linked to various factors such as heightened research and development investments, improvements in healTH*Care infrastructure, partnerships between academia and industry, increasing occurrence of cancer and genetic diseases, and the broadened utilization of biomarkers in drug development.

The market size of predictive biomarkers is predicted to witness consistent expansion in the upcoming years. The market value is set to reach $24.67 billion by 2029, with a compound annual growth rate (CAGR) of 4.2%. The forecast period growth can be attributed to factors such as the rising transition towards precision medicine, an increased focus on preventive healTH*Care, escalating healTH*Care spending, enhanced investment in biomarker-oriented diagnostics, the growth of biobanks and tissue repositories, and an increase in worldwide health awareness. Significant trends during this time will include the inclusion of artificial intelligence in biomarker evaluation, the rise of non-invasive biomarker testing, progression in biomarker-dependent digital health tools, advancement in single-cell sequencing technologies, real-time biosensing and monitoring systems development, and progress in bioinformatics tools for data integration.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20595

How Are Emerging Segments Shaping the Predictive Biomarkers Market Landscape?
The predictive biomarkers market covered in this report is segmented -

1) By Indication: Cancer, Metabolic Disease, Cardiovascular Disorder, Immunological Disorder, Other Indications
2) By Application: Screening, Analysis, Diagnosis, Prediction, Monitoring
3) By End User: Diagnostic Centers, Contract Research Organizations, Academic Research Institutes, Pharms And Biotech Companies, Other End Users

Subsegments:
1) By Cancer: Breast Cancer, Lung Cancer, Prostate Cancer, Colorectal Cancer, Ovarian Cancer, Leukemia And Lymphoma, Melanoma, Pancreatic Cancer, Kidney Cancer, Head And Neck Cancer
2) By Metabolic Disease: Type 1 and Type 2 Diabetes, Obesity, Metabolic Syndrome, Non-Alcoholic Fatty Liver Disease (NAFLD), Dyslipidemia, Insulin Resistance
3) By Cardiovascular Disorder: Atherosclerosis, Coronary Artery Disease, Heart Failure, Myocardial Infarction (Heart Attack), Arrhythmia, Hypertension, Stroke, Peripheral Arterial Disease
4) By Immunological Disorder: Autoimmune Diseases, Inflammatory Bowel Disease (IBD), Multiple Sclerosis, Psoriasis, Allergic Diseases, Asthma, Chronic Obstructive Pulmonary Disease (COPD), Immunodeficiency Disorders
5) By Other Indications: Neurological Disorders, Infectious Diseases, Renal Diseases, Osteoarthritis, Genetic Disorders, Respiratory Disorders

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20595&type=smp

Which Growth Factors Are Influencing Predictive Biomarkers Market Expansion?
The predictive biomarkers market is poised for growth, fueled by a surge in cancer diagnoses. Cancer, a medical condition marked by unrestricted cell proliferation that can infiltrate and migrate to other bodily regions, is primarily increasing due to ageing demographics, lifestyle transformations, and heightened exposure to risk elements such as tobacco, unhealthy eating habits, and environmental pollutants. Predictive biomarkers play a crucial role in cancer by identifying patients who are likely to respond to particular treatments, thereby facilitating tailored and more efficient therapy. For example, a report in April 2024 from the International Agency for Research on Cancer (IARC) - a France-based specialized affiliate of the World Health Organization (WHO) committed to studying cancer - stated that nearly 20 million fresh cancer diagnoses and roughly 10 million cancer-related fatalities occurred in 2022. Additionally, forecasts imply that the annual tally of fresh cancer diagnoses will escalate to 35 million by 2050, marking a 77% rise from 2022 figures. As a direct result, the escalating cancer diagnoses are anticipated to catalyze the expansion of the predictive biomarkers market.

Who Are the Dominant Players Across Different Predictive Biomarkers Market Segments?
Major companies operating in the predictive biomarkers market are Johnson & Johnson Services Inc, F Hoffmann-La Roche Ltd, Thermo Fisher Scientific Inc, Abbott Laboratories, Danaher Corporation, Merck KGaA, Siemens HealTH*Care GmbH, Agilent Technologies Inc, PerkinElmer Inc, Illumina Inc, Bio-Rad Laboratories Inc, QIAGEN GmbH, Almac Group Limited, ArcherDX Inc, Luminex Corporation, Guardant Health Inc, Meso Scale Diagnostics LLC, Myriad Genetics Inc, NanoString Technologies Inc, Fujirebio Inc, Asuragen Inc, Biognosys AG, Epigenomics AG, OncoCyte Corporation, Biomarker Technologies Inc

What Are the Latest Developing Trends in the Ambulatory X-Ray Devices Market?
Leading corporations in the predictive biomarkers market are striving to expedite biomarker development by leveraging technological advancements including artificial intelligence (AI) assisted biomarker discovery. This strategy is aimed at outpacing competitors by offering more personalized and effective therapies promptly. The method of AI-driven biomarker discovery facilitates the examination of expansive, intricate datasets, resulting in the recognition of predictive biomarkers that may not be discernible through conventional methods. For example, in July 2024, Scipher Medicine, Inc., an American precision immunology firm, introduced a project known as PRoBeNet (Predictive Response Biomarkers using Network Medicine) which has been geared towards accelerating the development of predictive response biomarkers for complex illnesses using AI and network biology. PRoBeNet identifies therapy response biomarkers by incorporating therapy-targeted proteins and disease-specific molecular signatures. It has proven effective for autoimmune diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease, and its utility extends to other complex diseases and stages of drug development.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/predictive-biomarkers-global-market-report

Which Geographic Regions Are Expected to Dominate the Predictive Biomarkers Market in the Coming Years?
North America was the largest region in the predictive biomarkers market in 2024. Europe is expected to be the fastest-growing region in the forecast period. The regions covered in the predictive biomarkers market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Predictive Biomarkers Market?
2. What is the CAGR expected in the Predictive Biomarkers Market?
3. What Are the Key Innovations Transforming the Predictive Biomarkers Industry?
4. Which Region Is Leading the Predictive Biomarkers Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the predictive biomarkers market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.